Psychedelic Treatment For PTSD Faces Misconduct Hurdle
Podcast |
Short Wave
Publisher |
NPR
Media Type |
audio
Categories Via RSS |
Astronomy
Daily News
Life Sciences
Nature
News
Science
Publication Date |
Jun 03, 2024
Episode Duration |
00:13:57
People with post-traumatic stress disorder (PTSD) may soon have a new treatment option: MDMA, the chemical found in ecstasy. In August, the Food and Drug Administration plans to decide whether MDMA-assisted therapy for PTSD will be approved for market based on years of research. But serious allegations of research misconduct may derail the approval timeline. NPR science reporter Will Stone talks to host Emily Kwong about the clinical trials on MDMA-assisted therapy research and a recent report questioning the validity of the results. Read Will's full story here. Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review